Atorvastatin, lovastatin, simvastatin Moderate DDI: monitor for increased statin adverse effects (e.g., myopathy) CYP3A4 Inhibitors may increase serum concentration of statinMOI: inhibition of CYP3A4. The gene discussed is CYP3A4; the disease is myopathy.